T. Rowe Price Investment Management, Inc. - Mar 31, 2025 SCHEDULE 13G Report for ASCENDIS PHARMA A/S - ADR ADR (ASND)

Filing Manager: T. Rowe Price Investment Management, Inc.
Reporting Manager: T. Rowe Price Investment Management, Inc.
Security: ASCENDIS PHARMA A/S - ADR ADR
Symbol: ASND
Shares outstanding: 61.1M shares
Disclosed Ownership: 3.05M shares
Ownership: 5%
Form type: SCHEDULE 13G
Date filed: 5/14/2025, 10:47 AM
Date of event: Mar 31, 2025
Next filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
T. Rowe Price Investment Management, Inc.	5%	3.05M	3.05M	0	Ellen York	Vice President